Compounds > alovudine
Page last updated: 2024-08-23

alovudine and Agnogenic Myeloid Metaplasia

alovudine has been researched along with Agnogenic Myeloid Metaplasia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Fayad, H; Ibrahim, F; Ismail, OM; Kohla, SA; Mohamed, SF; Nashwan, AJ; Nehmeh, SA; Sabbagh, AA; Soliman, DS; Szabados, L; Yassin, MA1
Barré, E; Cassinat, B; Chevret, S; Chomienne, C; de Beco, V; Dosquet, C; Kiladjian, JJ; Meignin, V; Merlet, P; Ouvrier, MJ; Toubert, ME; Vercellino, L1

Trials

1 trial(s) available for alovudine and Agnogenic Myeloid Metaplasia

ArticleYear
A study of 18F-FLT positron emission tomography/computed tomography imaging in cases of prefibrotic/early primary myelofibrosis and essential thrombocythemia.
    Medicine, 2020, Nov-06, Volume: 99, Issue:45

    Topics: Clinical Trials, Phase I as Topic; Dideoxynucleosides; Humans; Positron Emission Tomography Computed Tomography; Primary Myelofibrosis; Thrombocythemia, Essential

2020

Other Studies

1 other study(ies) available for alovudine and Agnogenic Myeloid Metaplasia

ArticleYear
Assessing Bone Marrow Activity in Patients with Myelofibrosis: Results of a Pilot Study of
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:10

    Topics: Aged; Bone Marrow; Dideoxynucleosides; Female; Humans; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Primary Myelofibrosis; Prognosis

2017